Back to Results
First PageMeta Content



AST-OPC1 Development Program for Spinal Cord Injury Asterias Biotherapeutics Inc. NYSE MKT: AST Investor Day
Add to Reading List

Open Document

File Size: 3,95 MB

Share Result on Facebook